Worth reading
75Important
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
986000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Completion of exercise and monthly exercise status of stock acquisition rights with an exercise price adjustment clause issued through a third-party allotment
Who receives how much986,000Shares
986,000 shares (new shares)
EVO FUND (9,860 units)
The lower thin line represents the existing number of shares to which these shares will be added.
Amount of funds to be raised
¥232,167,000 (amount raised; estimated net proceeds: Not disclosed)
Existing Shares and Increase
+12.50%Rate of increase
7,889,350 shares8,439,350Shares
986,000 shares equivalent against 7,889,350 shares issued (approximately 12.5%)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Subject to an exercise price adjustment clause. The monthly exercise prices were ¥211, ¥210, ¥290, ¥370, ¥341, ¥299, ¥279, ¥253, ¥241, ¥240 and ¥227.
Number of Stock Acquisition Rights
Total issued: 9,860 units; exercised: 9,860 units; unexercised balance: 0 units
Procedures under the Corporate Code of Conduct
Exercise restrictions under Article 434 of the Listing Regulations were complied with. The exercise ratio subject to the exercise restrictions was 9.2%.
Most recent equity financing
Timing 24 February 2026 / Type First Series stock acquisition rights subject to exercise price adjustment provisions, issued through a third-party allotment / Amount ¥232,167,000
Impact on Business Performance
The company states that it will work to increase corporate and shareholder value by strengthening its business base using the proceeds, realizing the potential value of its real estate holdings, improving profitability and enhancing capital efficiency. The specific impact on results is Not disclosed.
| Item | Details |
|---|---|
| Type of issuance or disposal | Completion of exercise and monthly exercise status of stock acquisition rights with an exercise price adjustment clause issued through a third-party allotment |
| Number of shares to be issued or disposed of | 986,000 shares (new shares) |
| Amount of funds to be raised | ¥232,167,000 (amount raised; estimated net proceeds: Not disclosed) |
| Intended allottee | EVO FUND (9,860 units) |
| Dilution Rate | 986,000 shares equivalent against 7,889,350 shares issued (approximately 12.5%) |
| Total number of issued shares | 7,889,350 shares → 8,439,350 shares (as of 16 June 2026, after reflecting 550,000 shares exercised during the month)（Approximately 7.0%） |
| Exercise price | Subject to an exercise price adjustment clause. The monthly exercise prices were ¥211, ¥210, ¥290, ¥370, ¥341, ¥299, ¥279, ¥253, ¥241, ¥240 and ¥227. |
| Number of Stock Acquisition Rights | Total issued: 9,860 units; exercised: 9,860 units; unexercised balance: 0 units |
| Procedures under the Corporate Code of Conduct | Exercise restrictions under Article 434 of the Listing Regulations were complied with. The exercise ratio subject to the exercise restrictions was 9.2%. |
| Most recent equity financing | Timing 24 February 2026 / Type First Series stock acquisition rights subject to exercise price adjustment provisions, issued through a third-party allotment / Amount ¥232,167,000 |
| Impact on Business Performance | The company states that it will work to increase corporate and shareholder value by strengthening its business base using the proceeds, realizing the potential value of its real estate holdings, improving profitability and enhancing capital efficiency. The specific impact on results is Not disclosed. |
Items this document does not state (17)
Issue price and disposal priceTotal issue valueEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Exercise was completed earlier than initially expected, around 24 July 2026, in light of market conditions and other factors. The company states that the exercise increased the number of tradable shares and advanced its efforts toward meeting the continued-listing criteria.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.